Evolus Stock

Evolus Net Margin

The Net Profit Margin of Evolus (EOLS) as of Aug 1, 2026 is -17.38 %. In the previous year, Net Profit Margin was -18.94 % — a change of -8.23% (higher).

Net Margin

-17.38 %

YoY

-8.23%

Last updated:

Net Profit Margin of Evolus is 2026 -17.38 % . Net Profit Margin of Evolus was 2025 -18.94 % . It decreases by -8.23% higher compared to the previous year.

Evolus's net margin stands at -17.4%, up from -47.0% several years earlier.

Access this data via the Eulerpool API

Evolus Stock analysis

What does Evolus do? Evolus Inc is an innovative biotechnology company based in Irvine, California, specializing in the development and distribution of aesthetic treatments. The company was founded in 2012 and has quickly become a market leader in the industry. Evolus is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Evolus stock

Net Profit Margin of Evolus is -17.38 % in 2026.

Access this data via the Eulerpool API

Margins — Evolus

All Key Metrics — Evolus